WASHINGTON DC (March 14, 2019) — The US Food and Drug Administration [FDA] today allowed marketing of a new device, ClearMate, intended to be used in an emergency-room setting to help treat patients suffering from carbon-monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.









